Clinical Trials Browser

Phase 2 × Biochemical Recurrent Prostate Cancer × 90 days × Clear all

NCT04206319 2026-03-16

Radium-223 in Biochemically Recurrent Prostate Cancer

Phase 2 Active not recruiting

Biochemical Recurrent Prostate Cancer